tiprankstipranks
Biofrontera AG (GB:0DOL)
LSE:0DOL
Holding GB:0DOL?
Track your performance easily

Biofrontera (0DOL) Financial Statements

0 Followers

Biofrontera Financial Overview

Biofrontera's market cap is currently ―. The company's EPS TTM is €0.026; its P/E ratio is 541.55; Biofrontera is scheduled to report earnings on April 24, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 9.01M$ 7.84M$ 7.91M$ 10.59M$ 8.90M
Gross Profit$ 9.01M$ 7.84M$ 7.91M$ 5.20M$ 4.31M
EBIT$ -5.67M$ 359.00K$ -3.54M-$ -6.19M
EBITDA$ -5.34M$ 659.00K$ -3.25M-$ -5.93M
Net Income Common Stockholders$ -5.67M$ -257.00K$ -10.44M$ 3.53M$ -6.34M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.87M$ 4.38M$ 3.82M$ 1.34M$ 3.42M
Total Assets$ 18.52M$ 21.57M$ 24.57M$ 27.93M$ 34.10M
Total Debt$ 994.00K$ 1.44M$ 3.67M$ 5.40M$ 2.81M
Net Debt$ -1.88M$ -2.94M$ -151.00K$ 4.06M$ -608.00K
Total Liabilities$ 12.99M$ 10.66M$ 26.42M$ 23.14M$ 33.07M
Stockholders Equity$ 5.53M$ 10.91M$ -5.42M$ 4.79M$ 1.04M
Cash Flow-
Free Cash Flow$ -1.35M$ -4.63M$ -3.38M--
Operating Cash Flow$ -1.30M$ -4.67M$ -3.33M$ -8.87M$ -2.00M
Investing Cash Flow-$ -45.00K$ 43.00K$ 73.00K$ 382.00K
Financing Cash Flow$ -298.00K$ 5.28M$ 5.80M$ 6.71M$ 591.00K
Currency in USD

Biofrontera Earnings and Revenue History

Biofrontera Debt to Assets

Biofrontera Cash Flow

Biofrontera Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis